Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02275793 · ClinicalTrials.gov registry record
The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure
A clinical trial, sponsored by University of Toledo Health Science Campus.
- Completed
- Registry status
- 90
- Enrollment target
NCT02275793: Completed study, sponsored by University of Toledo Health Science Campus.
NCT02275793 is a clinical trial that has completed, run by University of Toledo Health Science Campus. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02275793 has completed, sponsored by University of Toledo Health Science Campus.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
Peripheral blood and blood following a pulmonary wedge pressure will be obtained from patients undergoing right heart catheterizations.
Primary Outcome
Checking vital statistics on each patient at one year
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-09 |
What the finished NCT02275793 record still lists
NCT02275793 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02275793 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02275793 about?
NCT02275793 is a clinical study titled "The Regulation of Pulmonary Vascular Resistance in Patients With Heart Failure". Peripheral blood and blood following a pulmonary wedge pressure will be obtained from patients undergoing right heart catheterizations.
What is the current status of trial NCT02275793?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2011-09. Estimated completion is 2015-09.
Who is sponsoring clinical trial NCT02275793?
This trial is sponsored by University of Toledo Health Science Campus, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia